Oral antiepileptic drug.
Trade name Keppra.
High therapeutic index, with wide separation between therapeutic and toxic dosage.
Utilized for generalized and in partial-onset seizures.
Structurally unrelated to other antiepileptic drugs.
Binds to brain cell membranes in a reversible, and selective way.
Doses maintained without tolerance or signs of withdrawal after quitting treatment.
Exhibits linear kinetics.
Used as an adjunctive treatment of partial-onset seizures in adults with epilepsy.
Not associated with impaired balance.